Transplantation · 2018 · 29 citations · 30 references
MedicineHematologyCell TherapyStem Cell TransplantationTransplant ImmunologyAllogeneic Stem Cell TransplantationDonor MatchingGraft-versus-host DiseaseHematopoietic Stem Cell TransplantationTransplant ComplicationsTransplant Infectious ComplicationsAplastic Anemia TransplantationHaploidentical Donor MatchingHematopoietic Stem Cell Transplant ComplicationsSevere AnemiaStem Cell Donor MatchingSurvival RatesTransplantationTransplantation Outcome Assessment
BACKGROUND: Haploidentical donor (HID) allogeneic hematopoietic stem cell transplantation (HSCT) is an alternative curative treatment for patients with severe aplastic anemia (SAA) who do not have suitable matched related donors (MRD). The aim of this study was to compare the therapeutic outcomes of HID-HSCT with those of MRD-HSCT for SAA. METHODS: A total of 235 SAA patients who underwent HID-HSCT (116) or MRD-HSCT (119) at 11 transplantation centers from January 2007 to January 2016 were included. Complications and survival outcomes were evaluated and compared between the 2 groups. RESULTS: The HID group had a lower incidence of secondary graft failure but higher incidences of acute graft-versus-host disease (aGVHD) and chronic GVHD (cGVHD). However, the incidence of severe aGVHD (grades III-IV), poor graft function, and infections was comparable between groups. Patients in the HID group had a significantly lower survival and overall survival rates than those in the MRD group. The estimated 3-year survival rates for the MRD and HID groups were 82.82% and 75.00%, respectively. Ferritin levels, graft failure, poor graft function, severe aGVHD, and infections were the significant risk factors for survival. CONCLUSIONS: The overall survival rate is acceptable for patients who underwent HID-HSCT, making it a feasible treatment choice for SAA patients.
30
Alexandra H. Filipovich, Daniel J. Weisdorf, Steven Z. Pavletic et al. · Biology of Blood and Marrow Transplantation · 2005 · 3.5K citations
BM Camitta, Thomas Ed, DG Nathan et al. · Blood · 1976 · 558 citations · Full text
Dao-Pei Lu, Lujia Dong, Tong Wu et al. · Blood · 2005 · 515 citations · Full text
Medicine, Hematology, Immunology +16
Yu Wang, Qifa Liu, Lan‐Ping Xu et al. · Blood · 2015 · 492 citations · Full text
Medicine, Hematology, Oncology +14